AKT1 and hepatocellular carcinoma: Our work found that elevated FBXO32 levels promoted K48‐linked PHLPP2 polyubiquitination at K592 and K942 residues, leading to PHLPP2 degradation, PI3K–AKT signaling pathway activation, and subsequent malignant HCC progression.